Sulthiame (INN, BAN) is an antiepileptic drug used in the treatment of absence seizures in children and adolescents. It was first approved in Europe in 1973, and is available as a tablet, syrup or injectable solution. Sulthiame is thought to act on the γ-aminobutyric acid (GABA) receptors in the brain, increasing the amount of GABA available for use in the central nervous system. Common side effects include drowsiness, fatigue, dizziness, nausea, and vomiting.
Sulthiame is a medication used to treat seizures. It is a carbonic anhydrase inhibitor, which means it works by blocking the action of an enzyme called carbonic anhydrase. This enzyme is involved in the regulation of acid-base balance in the body. By blocking the action of carbonic anhydrase, sulthiame can help to reduce the acidity of the blood. This can help to reduce the excitability of nerve cells and prevent seizures.
Sulthiame is typically used as an add-on therapy, which means it is used in addition to other seizure medications. It is available in tablet form and is usually taken two or three times a day.
Sulthiame is a relatively well-tolerated medication, but it can cause some side effects, including drowsiness, dizziness, headache, and taste disturbances. It can also interact with other medications, so it is important to tell your doctor about all of the medications you are taking before starting sulthiame.